Lawsuits involving Ozempic (a GLP-1 receptor agonist medication) allege that some patients experienced severe gastrointestinal complications, including gastroparesis (delayed stomach emptying), persistent vomiting, and in some reports, bowel obstruction-like symptoms. These claims generally focus on whether risks were adequately communicated and how certain adverse events were managed in real-world use.
This page is designed to help readers understand what the reported symptoms mean, what to watch for, and what questions to ask a clinician if they have concerns. It is not medical advice, and any medication decisions should be made with a licensed healthcare provider.
At a glance
- Topic: Lawsuits and reports alleging severe gastroparesis and related GI events
- Commonly reported symptoms: Persistent nausea/vomiting, early satiety, severe abdominal pain, bloating
- Serious concerns: Dehydration, electrolyte imbalance, inability to keep food/fluids down, possible obstruction
- What to do: Seek medical care for severe symptoms and discuss medication risks/benefits with your clinician
- Do not stop abruptly: If you take Ozempic for diabetes, consult your prescriber before changing therapy
What is gastroparesis?
Gastroparesis is a condition where the stomach empties more slowly than normal, sometimes due to impaired nerve or muscle function. When the stomach empties slowly, food can remain in the stomach longer than it should, which may cause:
- Nausea and vomiting
- Feeling full quickly (early satiety)
- Bloating and abdominal discomfort
- Appetite loss and unintended weight changes
- Acid reflux or heartburn symptoms
Gastroparesis can range from mild to severe. Severe cases can make it difficult to maintain hydration and adequate nutrition.
Why GLP-1 drugs are discussed in this context
GLP-1 receptor agonists are known to affect appetite and slow gastric emptying as part of their mechanism of action. For many patients, this effect can contribute to improved blood sugar control and weight loss. However, in some individuals, slowed stomach emptying may become more pronounced and contribute to significant GI symptoms.
The central question in many lawsuits is whether certain severe outcomes—such as prolonged gastroparesis or obstruction-like events—occurred, and whether the warnings and risk communication were adequate for the level of severity reported.
Reported symptoms in lawsuits and patient reports
Reports often describe symptoms that go beyond typical, temporary nausea. These may include:
- Persistent vomiting lasting days or weeks
- Inability to tolerate food or fluids
- Severe abdominal pain or cramping
- Ongoing bloating and abdominal distention
- Constipation or very reduced bowel movements
- Repeated emergency department visits for dehydration
These symptoms can have many causes and do not automatically mean gastroparesis is present. A clinician may evaluate for medication effects, infection, gallbladder or pancreatic issues, intestinal obstruction, and other GI conditions.
When to seek urgent medical care
Seek urgent medical care if you experience:
- Persistent vomiting or inability to keep fluids down
- Severe abdominal pain, especially with bloating or distention
- Signs of dehydration (dizziness, fainting, very dark urine, confusion)
- Black/tarry stools, blood in vomit, or severe weakness
- No bowel movements or inability to pass gas with worsening pain
These can be signs of serious dehydration, electrolyte imbalance, or obstruction-like conditions that require prompt evaluation.
What to discuss with your clinician
If you are taking Ozempic (or a related GLP-1 medication) and have persistent GI symptoms, consider asking:
- Could my symptoms be related to slowed gastric emptying?
- What tests are appropriate (labs, imaging, gastric emptying study) given my symptoms?
- Should my dose be adjusted, paused, or switched—based on my risk profile?
- How can I manage hydration and nutrition safely while symptoms are evaluated?
- Are there warning signs that should prompt ER care?
If you use Ozempic for diabetes, it’s especially important to discuss alternatives before stopping, as blood sugar can rise when therapy changes.
Practical steps if you have concerns
Here are practical, non-medication-specific steps to help you prepare for a clinical conversation:
- Track symptoms: Note onset, severity, triggers, and how long symptoms last.
- Document dosing: Record dose changes and timing relative to symptom changes.
- List all meds/supplements: Some can affect GI motility or interact with therapy.
- Record hydration/food tolerance: Note what you can keep down and what you cannot.
- Keep visit records: If you went to urgent care/ER, keep discharge notes and lab results.
Frequently asked questions
Does Ozempic cause gastroparesis?
GLP-1 medications can slow gastric emptying, and some patients report significant symptoms. Whether a person develops true gastroparesis depends on the clinical evaluation and diagnostic criteria. If symptoms are severe or persistent, discuss them with a clinician promptly.
Should I stop Ozempic if I feel nauseous?
Do not stop prescription medication without medical guidance. Mild nausea can occur with dose changes, but persistent vomiting, severe pain, or inability to keep fluids down needs medical evaluation.
What tests are used to evaluate gastroparesis?
Clinicians may use lab work, imaging, and in some cases a gastric emptying study, depending on symptoms and clinical context. Your provider will decide what is appropriate.